Back
Integra Lifesciences Holdings Quote, Financials, Valuation and Earnings
Sell
31
IART
Integra Lifesciences Holdings
Last Price:
27.47
Seasonality Move:
3.55%
7 Day Trial
ALL ACCESS PASS
$
7
Integra Lifesciences Holdings Price Quote
$27.47
-0.02 (3.78%)
(Updated: May 17, 2024 at 3:40 AM ET)
Integra Lifesciences Holdings Key Stats
Sell
31
Integra Lifesciences Holdings (IART)
is a Sell
Day range:
$26.35 - $27.51
52-week range:
$22.36 - $50.78
Dividend yield:
0%
P/E ratio:
31.51
P/S ratio:
1.37
P/B ratio:
0.72%
Volume:
967.9K
Avg. volume:
798.2K
1-year change:
-47.55%
Market cap:
$2.1B
Revenue:
$1.5B
EPS:
$0.5
How Much Does Integra Lifesciences Holdings Make?
-
How Much Are Integra Lifesciences Holdings's Sales Annually?
IART Revenues are $1.5B -
How Much Profit Does Integra Lifesciences Holdings's Make A Year?
IART net income is $67.7M
Is Integra Lifesciences Holdings Growing As A Company?
-
What Is Integra Lifesciences Holdings's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.03% -
What Is Integra Lifesciences Holdings's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Integra Lifesciences Holdings Stock Price Performance
-
Did Integra Lifesciences Holdings Stock Go Up Last Month?
Integra Lifesciences Holdings share price went down by -15.96% last month -
Did IART's Share Price Rise Over The Last Year?
IART share price fell by -47.55% over the past 1 year
What Is Integra Lifesciences Holdings 52-Week High & Low?
-
What Is Integra Lifesciences Holdings’s 52-Week High Share Price?
Integra Lifesciences Holdings has traded as high as $50.78 over the past 52 weeks -
What Is Integra Lifesciences Holdings’s 52-Week Low Share Price?
Integra Lifesciences Holdings has traded as low as $22.36 over the past 52 weeks
Integra Lifesciences Holdings Price To Free Cash Flow
-
Is Integra Lifesciences Holdings Stock Overvalued?
Integra Lifesciences Holdings is trading at a price to free cash flow ratio of 34.40 -
Is Integra Lifesciences Holdings Stock Undervalued?
Integra Lifesciences Holdings EV to Free Cash Flow ratio is 23.35 -
What Is Integra Lifesciences Holdings’s Price Earnings Growth Ratio?
IART PEG ratio is 0.00 -
Is Integra Lifesciences Holdings Trading At A Premium To Earnings?
Integra Lifesciences Holdings EV to EBIT ratio is 14.38
Is It Risky To Buy Integra Lifesciences Holdings?
-
How Much Debt Does Integra Lifesciences Holdings Have?
Total long term debt quarterly is $0 -
How Much Cash Does Integra Lifesciences Holdings Have?
Cash and short term investments quarterly total is $663.1M -
What Is Integra Lifesciences Holdings’s Book Value Per Share?
Book value per share is 36.83
Is Integra Lifesciences Holdings Cash Flow Positive?
-
What Is IART Cash Flow From Operations?
Cash flow from operations (TTM) is $129.6M -
What Is Integra Lifesciences Holdings’s Cash Flow From Financing?
Cash flow from financing (TTM) is $291.4M -
What Is Integra Lifesciences Holdings’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$134.4M
Integra Lifesciences Holdings Return On Invested Capital
-
Is Management Doing A Good Job?
IART return on invested capital is 1.32% -
What Is Integra Lifesciences Holdings Return On Assets?
ROA measures how assets are converting to revenues and is 1.05% -
What Is IART Return On Equity?
ROE is a measure of profitability and is 2.48%
Integra Lifesciences Holdings Earnings Date & Stock Price
-
What Is Integra Lifesciences Holdings's Stock Price Today?
A single share of IART can be purchased today for 27.49 -
What Is Integra Lifesciences Holdings’s Stock Symbol?
Integra Lifesciences Holdings trades on the nasdaq under the ticker symbol: IART -
When Is Integra Lifesciences Holdings’s Next Earnings Date?
The next quarterly earnings date for Integra Lifesciences Holdings is scheduled on July 26, 2024 -
When Is IART's next ex-dividend date?
Integra Lifesciences Holdings's next ex-dividend date is May 17, 2024 -
How To Buy Integra Lifesciences Holdings Stock?
You can buy Integra Lifesciences Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Integra Lifesciences Holdings Competitors
-
Who Are Integra Lifesciences Holdings's Competitors?
Below is a list of companies who compete with Integra Lifesciences Holdings or are related in some way:
Integra Lifesciences Holdings Dividend Yield
Data Unavailable
Integra Lifesciences Holdings Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -0.34% |
| Revenue: | -3.14% | 1.91% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 7 |
| Sell Recommendations: | 1 |
| Price Target: | 33.80 |
| Upside from Last Price: | 22.95% |